Literature DB >> 22539281

From crucial to negligible: functional CD8⁺ T-cell responses and their dependence on CD4⁺ T-cell help.

Melanie Wiesel1, Annette Oxenius.   

Abstract

CD8(+) T cells play an important role in controlling pathogenic infections and are therefore key players in the immune response. It has been shown that among other factors CD4(+) T cells can shape the magnitude as well as the quality of primary and/or secondary CD8(+) T-cell responses. However, due to the complexity and the differences among diverse immunization or infection models, the overall requirement, the time points, as well as the specific mechanism(s) of CD4(+) T-cell help may differ substantially. Here, we summarize current knowledge about the differential requirement of CD4(+) T-cell help in promoting primary CD8(+) T-cell responses as well as establishing functional memory CD8(+) T cells in various experimental settings.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22539281     DOI: 10.1002/eji.201142205

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  61 in total

1.  CD4(+) T-cell dependence of primary CD8(+) T-cell response against vaccinia virus depends upon route of infection and viral dose.

Authors:  Zhuting Hu; Michael J Molloy; Edward J Usherwood
Journal:  Cell Mol Immunol       Date:  2014-12-29       Impact factor: 11.530

2.  Robust Anti-viral Immunity Requires Multiple Distinct T Cell-Dendritic Cell Interactions.

Authors:  Sarah Eickhoff; Anna Brewitz; Michael Y Gerner; Frederick Klauschen; Karl Komander; Hiroaki Hemmi; Natalio Garbi; Tsuneyasu Kaisho; Ronald Nathan Germain; Wolfgang Kastenmüller
Journal:  Cell       Date:  2015-08-18       Impact factor: 41.582

Review 3.  CD4 T cells in protection from influenza virus: Viral antigen specificity and functional potential.

Authors:  Andrea J Sant; Anthony T DiPiazza; Jennifer L Nayak; Ajitanuj Rattan; Katherine A Richards
Journal:  Immunol Rev       Date:  2018-07       Impact factor: 12.988

4.  Effect of entinostat on NK cell-mediated cytotoxicity against osteosarcoma cells and osteosarcoma lung metastasis.

Authors:  Simin Kiany; Gangxiong Huang; Eugenie S Kleinerman
Journal:  Oncoimmunology       Date:  2017-07-11       Impact factor: 8.110

Review 5.  T cell exhaustion during persistent viral infections.

Authors:  Shannon M Kahan; E John Wherry; Allan J Zajac
Journal:  Virology       Date:  2015-01-22       Impact factor: 3.616

6.  Longitudinal requirement for CD4+ T cell help for adenovirus vector-elicited CD8+ T cell responses.

Authors:  Nicholas M Provine; Rafael A Larocca; Pablo Penaloza-MacMaster; Erica N Borducchi; Anna McNally; Lily R Parenteau; David R Kaufman; Dan H Barouch
Journal:  J Immunol       Date:  2014-04-28       Impact factor: 5.422

7.  Immediate Dysfunction of Vaccine-Elicited CD8+ T Cells Primed in the Absence of CD4+ T Cells.

Authors:  Nicholas M Provine; Rafael A Larocca; Malika Aid; Pablo Penaloza-MacMaster; Alexander Badamchi-Zadeh; Erica N Borducchi; Kathleen B Yates; Peter Abbink; Marinela Kirilova; David Ng'ang'a; Jonathan Bramson; W Nicholas Haining; Dan H Barouch
Journal:  J Immunol       Date:  2016-07-22       Impact factor: 5.422

8.  Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunity.

Authors:  Alexey Berezhnoy; Iris Castro; Agata Levay; Thomas R Malek; Eli Gilboa
Journal:  J Clin Invest       Date:  2014-01       Impact factor: 14.808

9.  Orchestration of CD4 T cell epitope preferences after multipeptide immunization.

Authors:  Jacqueline Tung; Andrea J Sant
Journal:  J Immunol       Date:  2013-06-14       Impact factor: 5.422

10.  BCR-ABL-specific CD4+ T-helper cells promote the priming of antigen-specific cytotoxic T cells via dendritic cells.

Authors:  Norihiro Ueda; Rong Zhang; Minako Tatsumi; Tian-Yi Liu; Shuichi Kitayama; Yutaka Yasui; Shiori Sugai; Tatsuaki Iwama; Satoru Senju; Seiji Okada; Tetsuya Nakatsura; Kiyotaka Kuzushima; Hitoshi Kiyoi; Tomoki Naoe; Shin Kaneko; Yasushi Uemura
Journal:  Cell Mol Immunol       Date:  2016-05-15       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.